Panelists discuss how; the patient case presents a 47-Year-Old Woman with EGFR-mutated Advanced/Metastatic NSCLC. The patient ...

The following is a summary of “Prognostic impact of albuminuria in early-stage chronic kidney disease on cardiovascular outcomes: a cohort study,” published in the January 2025 issue of Cardiology by ...

and 0.844 for the combination of ACR and eGFR. Referring all study participants with CKD stage 3–4 to a specialist would have meant the referral of 4.7% of the entire cohort and 69.4% of ...

Though highly effective, medications for the prevention of chronic kidney disease progression are under-utilized, emphasizing the need for better use of prognostic tools.

Most patients with undiagnosed CKD had stage 3 (82%). Compared with CKD patients ... from 2017 to 2021 and ≥1 serum ...

The FDA has approved Ozempic (semaglutide) to reduce the risk of kidney disease worsening and cardiovascular death in those with T2D and CKD.

Chronic kidney disease has been linked to yo-yo dieting (also known as body-weight cycling) in the general population, which ...

Figure 2B shows the sensing signal of S1 versus eGFR. The transition from early-stage to late-stage CKD is marked by eGFR = 30 ml/min per 1.73 m 2 (Table 1). This value corresponds to a sensing ...

According to an important study performed by the International Society of Nephrology (ISN), StatSensor Creatinine/eGFR can be effectively used to improve the early detection of CKD and high-risk ...

The study enrolled 3533 participants with T2D and CKD (defined as eGFR 25 to 75mL/min/1.73m 2 and urinary albumin-to-creatinine ratio [UACR] >100 and <5000mg/g). Study participants were randomly ...